Market closedNon-fractional

Precision BioSciences/DTIL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Precision BioSciences

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Ticker

DTIL

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Durham, United States

Employees

109

DTIL Metrics

BasicAdvanced
$64M
Market cap
-
P/E ratio
-$6.62
EPS
1.74
Beta
-
Dividend rate
$64M
1.74
4.824
4.185
19.919
83.462
-15.15%
-11.10%
-51.66%
0.668
1.69
1.71
-0.525
88.25%
-79.59%
19.59%
-51.12%

What the Analysts think about DTIL

Analyst Ratings

Majority rating from 6 analysts.
Buy

DTIL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
48.57% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$18M
150.00%
Net income
$8.5M
-152.47%
Profit margin
48.57%
-120.99%

DTIL Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 188.85%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$3.00
-$2.10
-$4.06
$1.70
-
Expected
-$7.32
-$4.88
-$2.05
-$1.91
-$1.51
Surprise
-59.02%
-56.92%
98.29%
-188.85%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Precision BioSciences stock?

Precision BioSciences (DTIL) has a market cap of $64M as of July 06, 2024.

What is the P/E ratio for Precision BioSciences stock?

The price to earnings (P/E) ratio for Precision BioSciences (DTIL) stock is 0 as of July 06, 2024.

Does Precision BioSciences stock pay dividends?

No, Precision BioSciences (DTIL) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Precision BioSciences dividend payment date?

Precision BioSciences (DTIL) stock does not pay dividends to its shareholders.

What is the beta indicator for Precision BioSciences?

Precision BioSciences (DTIL) has a beta rating of 1.74. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Precision BioSciences stock

Buy or sell Precision BioSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing